Search for: "Bayer AG" Results 541 - 560 of 641
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 May 2009, 6:51 pm
Bayer AG and Bayer Corp., et al., No. 08-1194; cert. petition filed on Mar. 23, 2009, 2009 WL 797579. [read post]
6 May 2009, 10:06 pm
  The pharmaceutical representatives in question promote Bayer products to doctors and hospitals, but they don't actually enter into bindings sales agreements. [read post]
5 May 2009, 8:11 pm
Bayer Corporation and the opinion/request for answers is here.SHAW VALENZA LLP - http://shawvalenza.com [read post]
1 May 2009, 11:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
1 May 2009, 9:00 am
  Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement suit over Barr’s ANDA to manufacture generic Alimta (Patent Docs) Arthrotech (Diclofenac/Misoprostol) – US: Pfizer files patent infringement suit against Teva over generic Arthrotech ANDA (Patent Docs) Enablex (Darifenacin hydrobromide) – US: Watson files ANDA to market generic Enablex prior to expiration of Novartis’ patent (GenericsWeb) Flanax (Naproxen) –… [read post]
15 Apr 2009, 4:44 am
We've been doing some research in anticipation of the upcoming ALI meeting at which the Principles of the Law of Aggregate Litigation will be voted on (we hope ALI members interested in class actions and the like will come out, debate the issues, and vote), and in the spirit of cross-fertilization, we thought we'd share it with our readers. [read post]
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
19 Mar 2009, 1:07 am
“Rivaroxaban, from Bayer AG’s (BAYRY) health-care unit and Johnson & Johnson (JNJ), faces a review by an FDA panel Thursday. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
3 Mar 2009, 5:00 am
(a citizen of Delaware and New Jersey), and Bayer AG (a German corporation). [read post]
5 Feb 2009, 12:19 pm
As readers who use our No Injury Scorecard know, we're very interested in identifying situations where plaintiffs - and especially consumer fraud plaintiffs - get dismissed because they don't have (or don't choose to allege) a legally sufficient injury.Why? [read post]
8 Jan 2009, 2:57 pm
Last month, Abbott Laboratories was sued by Bayer AG’s HealthCare unit alleging that drugmaker Abbott Laboratories’ best-selling drug, the arthritis drug Humira, infringes on a Bayer patent. [read post]
4 Jan 2009, 1:15 pm
TMCNews reports on 4 Jan 09:German chemical giant Bayer AG applied for a patent in Japan on June 15, 2007, for a technique to generate induced pluripotent stem cells, or iPS cells, from human cells, according to Patent Office data released by Sunday [Jan 4].The application was submitted around three months before a Japanese team led by Kyoto University professor Shinya Yamanaka announced the successful generation of iPS cells from human cells.See alsoSATURDAY, SEPTEMBER 13, 2008. [read post]
30 Dec 2008, 1:17 pm
***Separately, wsj on Humira: A unit of Bayer AG has filed a patent-infringement lawsuit in a U.S. court [ED Texas] against Abbott Laboratories relating to the autoimmune drug Humira, which is Abbott's top-selling product.Humira is an injectable drug for treating multiple immune system-related diseases, including rheumatoid and other types of arthritis, the intestinal disorder Crohn's disease and the skin condition plaque psoriasis. [read post]
26 Nov 2008, 5:39 pm
This time it's Bayer AG, which allegedly paid medical equipment suppliers to encourage their customers to use Bayer products. [read post]